These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 25665872)

  • 1. Behavioural profile of Wistar rats with unilateral striatal lesion by quinolinic acid (animal model of Huntington disease) post-injection of apomorphine and exposure to static magnetic field.
    Giorgetto C; Silva EC; Kitabatake TT; Bertolino G; de Araujo JE
    Exp Brain Res; 2015 May; 233(5):1455-62. PubMed ID: 25665872
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neural progenitor implantation restores metabolic deficits in the brain following striatal quinolinic acid lesion.
    Visnyei K; Tatsukawa KJ; Erickson RI; Simonian S; Oknaian N; Carmichael ST; Kornblum HI
    Exp Neurol; 2006 Feb; 197(2):465-74. PubMed ID: 16310773
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuropathology and behavioral impairments in Wistar rats with a 6-OHDA lesion in the substantia nigra compacta and exposure to a static magnetic field.
    Bertolino G; Dutra Souza HC; de Araujo JE
    Electromagn Biol Med; 2013 Dec; 32(4):527-35. PubMed ID: 23631668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transplanted adult neural progenitor cells survive, differentiate and reduce motor function impairment in a rodent model of Huntington's disease.
    Vazey EM; Chen K; Hughes SM; Connor B
    Exp Neurol; 2006 Jun; 199(2):384-96. PubMed ID: 16626705
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Asymmetrical motor behavior in rats with unilateral striatal excitotoxic lesions as revealed by the elevated body swing test.
    Borlongan CV; Randall TS; Cahill DW; Sanberg PR
    Brain Res; 1995 Apr; 676(1):231-4. PubMed ID: 7796175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Behavioral/neurophysiological investigation of effects of combining a quinolinic acid entopeduncular lesion with a fetal mesencephalic tissue transplant in striatum of the 6-OHDA hemilesioned rat.
    Olds ME; Jacques DB; Kpoyov O
    Synapse; 2003 Jul; 49(1):1-11. PubMed ID: 12710010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of neuroprotection by embryonic striatal grafts in a double lesion rat model of striatonigral degeneration (multiple system atrophy).
    Puschban Z; Waldner R; Seppi K; Stefanova N; Humpel C; Scherfler C; Levivier M; Poewe W; Wenning GK
    Exp Neurol; 2000 Jul; 164(1):166-75. PubMed ID: 10877927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous administration of human neural stem cells induces functional recovery in Huntington's disease rat model.
    Lee ST; Chu K; Park JE; Lee K; Kang L; Kim SU; Kim M
    Neurosci Res; 2005 Jul; 52(3):243-9. PubMed ID: 15896865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Donor age dependent graft development and recovery in a rat model of Huntington's disease: histological and behavioral analysis.
    Schackel S; Pauly MC; Piroth T; Nikkhah G; Döbrössy MD
    Behav Brain Res; 2013 Nov; 256():56-63. PubMed ID: 23916743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Reduction of apomorphine-induced rotation in rats with additional destruction of the pedunculopontine nucleus contralateral to the unilateral nigrostriatal lesion].
    Kannari K; Maeda T; Matsunaga M; Suda T
    No To Shinkei; 1998 Jan; 50(1):33-7. PubMed ID: 9493196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prenatal ethanol enhances rotational behavior to apomorphine in the 24-month-old rat offspring with small striatal lesion.
    Gomide VC; Chadi G
    Neurotoxicol Teratol; 2004; 26(3):417-27. PubMed ID: 15113603
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine anaesthesia interferes with the quinolinic acid-induced lesion in a rat model of Huntington's disease.
    Jiang W; Büchele F; Papazoglou A; Döbrössy M; Nikkhah G
    J Neurosci Methods; 2009 May; 179(2):219-23. PubMed ID: 19428530
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and anatomical effects of quinolinic acid in the striatum of the hemiparkinsonian rat.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2005 Jan; 55(1):26-36. PubMed ID: 15499610
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurogenesis in the striatum of the quinolinic acid lesion model of Huntington's disease.
    Tattersfield AS; Croon RJ; Liu YW; Kells AP; Faull RL; Connor B
    Neuroscience; 2004; 127(2):319-32. PubMed ID: 15262322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenosine A2A receptor blockade before striatal excitotoxic lesions prevents long term behavioural disturbances in the quinolinic rat model of Huntington's disease.
    Scattoni ML; Valanzano A; Pezzola A; March ZD; Fusco FR; Popoli P; Calamandrei G
    Behav Brain Res; 2007 Jan; 176(2):216-21. PubMed ID: 17123640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal characterization of cognitive and motor deficits in an excitotoxic lesion model of striatal dysfunction in non-human primates.
    Lavisse S; Williams S; Lecourtois S; van Camp N; Guillermier M; Gipchtein P; Jan C; Goutal S; Eymin L; Valette J; Delzescaux T; Perrier AL; Hantraye P; Aron Badin R
    Neurobiol Dis; 2019 Oct; 130():104484. PubMed ID: 31132407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deficits in striatal dopamine D(2) receptors and energy metabolism detected by in vivo microPET imaging in a rat model of Huntington's disease.
    Araujo DM; Cherry SR; Tatsukawa KJ; Toyokuni T; Kornblum HI
    Exp Neurol; 2000 Dec; 166(2):287-97. PubMed ID: 11085894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Electrolytic lesion of globus pallidus ameliorates the behavioral and neurodegenerative effects of quinolinic acid lesion of the striatum: a potential novel treatment in a rat model of Huntington's disease.
    Joel D; Ayalon L; Tarrasch R; Veenman L; Feldon J; Weiner I
    Brain Res; 1998 Mar; 787(1):143-8. PubMed ID: 9518584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hemiparkinsonian rats rotate toward the side with the weaker dopaminergic neurotransmission.
    Da Cunha C; Wietzikoski EC; Ferro MM; Martinez GR; Vital MA; Hipólide D; Tufik S; Canteras NS
    Behav Brain Res; 2008 Jun; 189(2):364-72. PubMed ID: 18328580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlations between behavioural and oxidative parameters in a rat quinolinic acid model of Huntington's disease: protective effect of melatonin.
    Antunes Wilhelm E; Ricardo Jesse C; Folharini Bortolatto C; Wayne Nogueira C
    Eur J Pharmacol; 2013 Feb; 701(1-3):65-72. PubMed ID: 23340221
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.